Document Detail

Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
MedLine Citation:
PMID:  10361626     Owner:  NLM     Status:  MEDLINE    
Because of its unique features, the contraceptive effectiveness and tolerance during breast-feeding of 16-methylene-17 alpha-acetoxy-19-nor-4-pregnene-3,20-dione (elcometrine), delivered within a single subdermal capsule of medical grade polydimethylsiloxane, was investigated. Unlike other progestational steroids, elcometrine has no affinity for androgen and estrogen receptors and is inactive by the oral route. A total of 66 breast-feeding women receiving elcometrine by the subdermal route were enrolled in the study, and 69 women who elected to use Copper-T380 intrauterine devices (IUD) served as control subjects. The women and their infants were observed until the end of the first postpartum year. There were no significant differences in growth and development measurements among the infants in the elcometrine and control groups. The percentage of infants continuing to breast-feed at 3 and 6 months was significantly higher in the elcometrine group. There were no significant differences between the concentration of elcometrine in the mother's blood and milk. At 75 days, blood levels of elcometrine in the infants were near the undetectable and were significantly lower than the levels in maternal blood or milk (p < 0.01). In 15 of 25 infants, blood levels of elcometrine were at the limit of assay sensitivity or undetectable. Two pregnancies occurred in women using IUD, whereas none occurred in those using implants. There were menstrual bleeding irregularities in both groups. A single elcometrine capsule placed subcutaneously at 6-monthly intervals appears to be an effective method of contraception for lactating women and results in blood concentrations of nursing infants at or near undetectable levels.
Discusses the effects of the use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women in Maternidade Climerio de Oliveira in Salvador, Bahia, Brazil. A total of 135 women aged 18-35 years having a singleton term delivery, fully breast-feeding on demand, planning to breast-feed for 6 months postpartum, and requesting effective contraception were recruited. The method was initiated for 6 weeks postpartum. Results showed that 66 breast-feeding women used elcometrine implants, while 69 women preferred an IUD insertion. The contraceptive efficacy of lactation is high for women breast-feeding on demand, particularly in those who remain in amenorrhea during the 6 months postpartum; in these women, elcometrine implant and IUD prevented pregnancy effectively. Breast-feeding was significantly higher (p 0.05) in the elcometrine group at 3 and 6 months, while at 9 and 12 months there was no statistical difference. The differences in type, frequency of supplementary feeding, and anthropometric measures between the two contraceptive groups were not significant. Menstrual irregularities were present in both groups. Thus, elcometrine could be best alternative and the most effective method of contraception for lactating women.
E M Coutinho; C Athayde; C Dantas; C Hirsch; I Barbosa
Related Documents :
8296786 - Proportional hazards analysis of diarrhea due to enterotoxigenic escherichia coli and b...
2761576 - Maternal alcohol use during breast-feeding and infant mental and motor development at o...
11799376 - Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection...
1501036 - Perforated pseudomembranous colitis in the breast-fed infant.
16182036 - Glucose production in response to glucagon is comparable in preterm aga and sga infants.
1291496 - Effects of maternal labetalol on the newborn infant.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Contraception     Volume:  59     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-07-23     Completed Date:  1999-07-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  115-22     Citation Subset:  IM; J    
Maternidade Climério de Oliveira, Federal University of Bahia, Salvador, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Constitution
Body Weight
Breast Feeding*
Child Development*
Contraceptive Agents, Female / administration & dosage*,  pharmacokinetics
Drug Implants
Intrauterine Devices, Copper*
Milk, Human / chemistry
Norprogesterones / administration & dosage*,  pharmacokinetics
Postpartum Period*
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Drug Implants; 0/Norprogesterones; 7759-35-5/ST 1435

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in Chi...
Next Document:  A longitudinal study of changes in endometrial microvascular density in Norplant implant users.